Hematology

According to research presented at the EAHAD 2024 Annual Congress, nurse-led education empowers female hemophilia carriers across life stages.

A recent study found that patients with monoclonal gammopathy of undetermined significance who maintain a healthy weight have a lower risk of progression to multiple myeloma.

CVT patients face a significantly higher cancer risk, especially in the first year and up to 10 years after diagnosis.

BMT survivors face a higher risk of skin cancer, with age, graft-vs-host disease, and treatment influencing outcomes.

ICI treatment before transplant enhances survival in relapsed Hodgkin lymphoma, though it increases the risk of acute GVHD.

Detectable antibodies reduce COVID-19 risk in immunosuppressed individuals, emphasizing the need for tailored protection strategies.

The NHS has approved exa-cel, a revolutionary gene-editing therapy for sickle cell disease, offering hope for a cure.

Shared care after HCT improves quality of life at day 100 without affecting survival, offering a viable post-transplant model.